KIORA PHARMACEUTICALS INC
Ticker: 1372514
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY2024 | Q2 FY2024 | Q1 FY2024 | Q1 FY2024 |
|---|---|---|---|---|
| INCOME | ||||
| Revenue | 0.02+0.0% | 0.02-99.9% | 16.00+0.0% | 16.00 |
| Total Income | 0.02+0.0% | 0.02-99.9% | 16.00+0.0% | 16.00 |
| EXPENSES | ||||
| Expenditure | 2.56+0.0% | 2.56-7.9% | 2.78+0.0% | 2.78 |
| Tax | — | 0.00 | — | 0.00 |
| PROFIT | ||||
| PBT | — | -2.22 | — | 13.45 |
| Net Profit | -2.22+0.0% | -2.22-116.5% | 13.45+0.0% | 13.45 |
| KEY METRICS | ||||
| OPM % | -100.00% | -100.00%-182.64pp | 82.64% | 82.64% |
| NPM % | -100.00% | -100.00%-184.08pp | 84.08% | 84.08% |
| EPS | -0.53+0.0% | -0.53-201.9% | 0.52-88.9% | 4.67 |
Corporate Events
Board MeetingKPRX
202610Jun
Board Meeting
Annual Meeting of Stockholders to elect Class II Directors, …
SEC Filing ↗ Board MeetingKPRX
202617Apr
Board Meeting
Eric J. Daniels, Chief Development Officer of Kiora Pharmace…
SEC Filing ↗